ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 49 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q2 2022. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $751,489 | -31.5% | 6,483,945 | 0.0% | 0.00% | – |
| Q4 2022 | $1,097,732 | -14.6% | 6,483,945 | +0.1% | 0.00% | – |
| Q3 2022 | $1,286,000 | -60.4% | 6,480,688 | 0.0% | 0.00% | – |
| Q2 2022 | $3,247,000 | -12.3% | 6,480,688 | 0.0% | 0.00% | – |
| Q1 2022 | $3,701,000 | -6.2% | 6,480,688 | -0.6% | 0.00% | – |
| Q4 2021 | $3,944,000 | -37.5% | 6,518,856 | +0.1% | 0.00% | – |
| Q3 2021 | $6,315,000 | -9.1% | 6,509,454 | +3.1% | 0.00% | – |
| Q2 2021 | $6,945,000 | +28.9% | 6,313,841 | +10.2% | 0.00% | – |
| Q1 2021 | $5,387,000 | +438.2% | 5,731,522 | +177.7% | 0.00% | – |
| Q4 2020 | $1,001,000 | -34.6% | 2,063,723 | +5.6% | 0.00% | – |
| Q3 2020 | $1,530,000 | +50.1% | 1,953,423 | +2.8% | 0.00% | – |
| Q2 2020 | $1,019,000 | +51.4% | 1,899,551 | +0.7% | 0.00% | – |
| Q1 2020 | $673,000 | -49.1% | 1,886,237 | 0.0% | 0.00% | – |
| Q4 2019 | $1,322,000 | -2.7% | 1,886,237 | -2.2% | 0.00% | – |
| Q3 2019 | $1,359,000 | -41.6% | 1,929,094 | +7.7% | 0.00% | – |
| Q2 2019 | $2,328,000 | -35.6% | 1,791,266 | +4.5% | 0.00% | – |
| Q1 2019 | $3,616,000 | +51.1% | 1,713,768 | +61.1% | 0.00% | – |
| Q4 2018 | $2,393,000 | -58.2% | 1,063,512 | -35.1% | 0.00% | – |
| Q3 2018 | $5,731,000 | +38.9% | 1,637,513 | +27.1% | 0.00% | – |
| Q2 2018 | $4,125,000 | -8.0% | 1,288,868 | +0.6% | 0.00% | – |
| Q1 2018 | $4,484,000 | -17.7% | 1,281,068 | +3.5% | 0.00% | – |
| Q4 2017 | $5,446,000 | -7.9% | 1,237,796 | +9.3% | 0.00% | – |
| Q3 2017 | $5,914,000 | +20.6% | 1,132,029 | +20.1% | 0.00% | – |
| Q2 2017 | $4,903,000 | +49.5% | 942,940 | +22.2% | 0.00% | – |
| Q1 2017 | $3,280,000 | +52.3% | 771,773 | +12.9% | 0.00% | – |
| Q4 2016 | $2,154,000 | +14.6% | 683,799 | +24.7% | 0.00% | – |
| Q3 2016 | $1,880,000 | +100.0% | 548,314 | +63.3% | 0.00% | – |
| Q2 2016 | $940,000 | -44.4% | 335,814 | +21.8% | 0.00% | – |
| Q1 2016 | $1,690,000 | +19.4% | 275,617 | +5.2% | 0.00% | – |
| Q4 2015 | $1,415,000 | -99.3% | 262,085 | -94.9% | 0.00% | -100.0% |
| Q3 2015 | $189,665,000 | +17860.7% | 5,185,244 | +1962.7% | 0.01% | – |
| Q2 2015 | $1,056,000 | +13.4% | 251,382 | +6.4% | 0.00% | – |
| Q1 2015 | $931,000 | +151.6% | 236,240 | +294.0% | 0.00% | – |
| Q4 2014 | $370,000 | +262.7% | 59,958 | +175.2% | 0.00% | – |
| Q3 2014 | $102,000 | – | 21,788 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Capital CS Group, LLC | 75,669 | $38,000 | 0.04% |
| Founders Capital Management | 18,000 | $9,000 | 0.01% |
| Verdence Capital Advisors LLC | 58,382 | $29,000 | 0.00% |
| WOLFF WIESE MAGANA LLC | 10,740 | $5,000 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 93,669 | $47,000 | 0.00% |
| Affinity Capital Advisors, LLC | 13,180 | $7,000 | 0.00% |
| Tower Research Capital LLC (TRC) | 171,928 | $86,000 | 0.00% |
| B. Riley Wealth Advisors, Inc. | 25,210 | $13,000 | 0.00% |
| EDMOND DE ROTHSCHILD HOLDING S.A. | 100,000 | $50,000 | 0.00% |
| MGO ONE SEVEN LLC | 10,615 | $5,000 | 0.00% |